Respiratory virus replication

Respiratory virus replication" refers to the complex intracellular processes by which respiratory viruses, including influenza viruses, coronaviruses, respiratory syncytial virus, and others, synthesize new viral genomes and assemble progeny virions within infected host cells. This involves tightly regulated steps orchestrated by virus-encoded replication complexes such as RNA-dependent RNA polymerases and associated viral or host factors[1][2][3][4][5][7]. Pharmacological inhibition of key replicative enzymes, such as the RNA polymerase complex, is a major antiviral strategy for several respiratory viruses[2][4][6]. However, "respiratory virus replication" itself is a process, not a unifying single molecular target or receptor, so it is not a canonical drug target per se. There is a category error in identifying "respiratory virus replication" as a molecular target; instead, each virus has its own replication proteins and complexes (such as influenza RNA polymerase, coronavirus RdRp (nsp12), or RSV L polymerase) that serve as actual therapeutic targets[1][2][3][4]. This entry is returned as "is_incorrect: true" due to these reasons.

Other names

Replication of respiratory virusesViral replication (respiratory)Respiratory virus life cycle

Inhibition of viral RNA-dependent RNA polymerase, Inhibition of viral enzyme function, Blockade of virion assembly, Interference with viral entry or release